This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Ferrous chloride is an iron supplement indicated in parenteral nutrition.
- Generic Name
- Ferrous chloride
- DrugBank Accession Number
- DB13569
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Ferrous chloride (DB13569)
- Weight
- Average: 126.75
Monoisotopic: 125.872641 - Chemical Formula
- Cl2Fe
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAlendronic acid Ferrous chloride can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium Phosphate Ferrous chloride can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. Calcium phosphate dihydrate Ferrous chloride can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy. Carbidopa Ferrous chloride can cause a decrease in the absorption of Carbidopa resulting in a reduced serum concentration and potentially a decrease in efficacy. Cinoxacin Ferrous chloride can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Product Ingredients
Ingredient UNII CAS InChI Key Ferrous chloride tetrahydrate Not Available 13478-10-9 WSSMOXHYUFMBLS-UHFFFAOYSA-L - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Nutritrace Concentrate for solution for infusion Ferrous chloride tetrahydrate (6.958 mg/10ml) + Chromic chloride hexahydrate (0.053 mg/10ml) + Cupric chloride dihydrate (2.046 mg/10ml) + Manganese chloride tetrahydrate (1.979 mg/10ml) + Potassium Iodide (0.166 mg/10ml) + Sodium selenite pentahydrate (0.0789 mg/10ml) + Sodium fluoride (1.26 mg/10ml) + Sodium molybdate dihydrate (0.0242 mg/10ml) + Zinc chloride (6.815 mg/10ml) Solution Intravenous B. BRAUN SINGAPORE PTE LTD 2013-04-22 Not applicable Singapore 
Tracutil - Konzentrat zur Herstellung einer Infusionslösung Ferrous chloride (695.8 mcg/ml) + Chromic chloride (5.3 mcg/ml) + Cupric Chloride (204.6 mcg/ml) + Manganese chloride (197.9 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (7.89 mcg/ml) + Sodium fluoride (126 mcg/ml) + Sodium molybdate (2.42 mcg/ml) + Zinc chloride (681.5 mcg/ml) Injection, solution, concentrate Intravenous B. Braun Melsungen Ag 2001-02-16 Not applicable Austria 
TRACUTIL® 10 ML AMPOLLAS Ferrous chloride tetrahydrate (6.958 mg) + Chromic chloride hexahydrate (0.053 mg) + Cupric chloride dihydrate (2.046 mg) + Manganese chloride tetrahydrate (1.979 mg) + Potassium Iodide (0.166 mg) + Sodium selenite pentahydrate (0.0789 mg) + Sodium fluoride (1.26 mg) + Sodium molybdate dihydrate (0.0242 mg) + Zinc chloride (6.815 mg) Solution, concentrate Intravenous B. BRAUN MEDICAL S.A. 2006-11-10 2015-08-10 Colombia 
Categories
- ATC Codes
- B03AA05 — Ferrous chloride
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a transition metal.
- Kingdom
- Inorganic compounds
- Super Class
- Mixed metal/non-metal compounds
- Class
- Transition metal salts
- Sub Class
- Transition metal chlorides
- Direct Parent
- Transition metal chlorides
- Alternative Parents
- Inorganic chloride salts
- Substituents
- Inorganic chloride salt / Inorganic salt / Transition metal chloride
- Molecular Framework
- Not Available
- External Descriptors
- iron coordination entity (CHEBI:30812)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- S3Y25PHP1W
- CAS number
- 7758-94-3
- InChI Key
- NMCUIPGRVMDVDB-UHFFFAOYSA-L
- InChI
- InChI=1S/2ClH.Fe/h2*1H;/q;;+2/p-2
- IUPAC Name
- λ²-iron(2+) ion dichloride
- SMILES
- [Cl-].[Cl-].[Fe++]
References
- General References
- BASG: Tracutil (Chromic Chloride, Cupric Chloride, Ferrous Chloride, Manganese, Potassium Iodide, Selenious Acid, Sodium Fluoride, Sodium Molybdate, Zinc Chloride) Intravenous Injection [Link]
- External Links
- ChemSpider
- 22866
- 24940
- ChEBI
- 30812
- ChEMBL
- CHEMBL3183704
- Wikipedia
- Iron(II)_chloride
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intravenous 0.053 mg/10ml Injection, solution, concentrate Intravenous Solution, concentrate Intravenous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 33.1 mg/mL ALOGPS logP 0.98 ALOGPS logP 0.61 Chemaxon logS -0.58 ALOGPS pKa (Strongest Acidic) -7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 5.62 m3·mol-1 Chemaxon Polarizability 2.39 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 23, 2017 20:44 / Updated at May 29, 2021 18:11